HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effects of fluoxetine on decompression sickness in mice.

Abstract
Massive bubble formation after diving can lead to decompression sickness (DCS) that can result in central nervous system disorders or even death. Bubbles alter the vascular endothelium and activate blood cells and inflammatory pathways, leading to a systemic pathophysiological process that promotes ischemic damage. Fluoxetine, a well-known antidepressant, is recognized as having anti-inflammatory properties at the systemic level, as well as in the setting of cerebral ischemia. We report a beneficial clinical effect associated with fluoxetine in experimental DCS. 91 mice were subjected to a simulated dive at 90 msw for 45 min before rapid decompression. The experimental group received 50 mg/kg of fluoxetine 18 hours before hyperbaric exposure (n = 46) while controls were not treated (n = 45). Clinical assessment took place over a period of 30 min after surfacing. At the end, blood samples were collected for blood cells counts and cytokine IL-6 detection. There were significantly fewer manifestations of DCS in the fluoxetine group than in the controls (43.5% versus 75.5%, respectively; p = 0.004). Survivors showed a better and significant neurological recovery with fluoxetine. Platelets and red cells were significantly decreased after decompression in controls but not in the treated mice. Fluoxetine reduced circulating IL-6, a relevant marker of systemic inflammation in DCS. We concluded that fluoxetine decreased the incidence of DCS and improved motor recovery, by limiting inflammation processes.
AuthorsJean-Eric Blatteau, Sandrine Barre, Aurelie Pascual, Olivier Castagna, Jacques H Abraini, Jean-Jacques Risso, Nicolas Vallee
JournalPloS one (PLoS One) Vol. 7 Issue 11 Pg. e49069 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID23145072 (Publication Type: Journal Article)
Chemical References
  • Protective Agents
  • Fluoxetine
Topics
  • Animals
  • Decompression Sickness (drug therapy, pathology)
  • Diving (physiology)
  • Embolism, Air (drug therapy, pathology)
  • Endothelium, Vascular (drug effects, pathology)
  • Fluoxetine (administration & dosage)
  • Humans
  • Mice
  • Platelet Count
  • Protective Agents (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: